NEA Management Company’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,952,957
Closed -$32.5M 62
2022
Q3
$32.5M Hold
3,952,957
1.62% 20
2022
Q2
$25.9M Hold
3,952,957
1.33% 18
2022
Q1
$22.1M Sell
3,952,957
-1
-0% -$4 0.64% 25
2021
Q4
$18.5M Hold
3,952,958
0.37% 31
2021
Q3
$24.4M Hold
3,952,958
0.29% 33
2021
Q2
$26.1M Hold
3,952,958
0.34% 36
2021
Q1
$28.9M Hold
3,952,958
0.65% 32
2020
Q4
$22.8M Hold
3,952,958
0.6% 32
2020
Q3
$23.5M Hold
3,952,958
0.99% 27
2020
Q2
$20.4M Buy
3,952,958
+1,428,571
+57% +$9.02M 0.82% 25
2020
Q1
$9.14M Hold
2,524,387
0.48% 32
2019
Q4
$15.8M Hold
2,524,387
0.75% 23
2019
Q3
$21.3M Hold
2,524,387
1.77% 17
2019
Q2
$16.9M Buy
2,524,387
+434,783
+21% +$3.72M 1.18% 21
2019
Q1
$17.1M Hold
2,089,604
0.89% 25
2018
Q4
$33.4M Buy
2,089,604
+219,800
+12% +$4.84M 1.33% 13
2018
Q3
$61.9M Buy
1,869,804
+91,432
+5% +$2.35M 2.67% 14
2018
Q2
$40.1M Buy
1,778,372
+142,103
+9% +$3.37M 1.88% 15
2018
Q1
$47.5M Hold
1,636,269
2.11% 12
2017
Q4
$45.7M Hold
1,636,269
1.89% 12
2017
Q3
$59.7M Hold
1,636,269
2.09% 11
2017
Q2
$36.3M Hold
1,636,269
1.32% 16
2017
Q1
$9.65M Buy
1,636,269
+600,000
+58% +$4.33M 0.34% 25
2016
Q4
$5.6M Hold
1,036,269
0.22% 25
2016
Q3
$9.22M Hold
1,036,269
0.41% 23
2016
Q2
$9.95M Buy
+1,036,269
New +$9.99M 0.52% 22

Other funds holding AVEO

NEA Management Company's AVEO Position: Q4 2022 in Review

NEA Management Company sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2022, closing a stake of 3,952,957 shares — an estimated $32.5M sold.

NEA Management Company first reported a position in AVEO in Q2 2016 and held it in 26 quarters. The position peaked at $61.9M in Q3 2018. 110 funds tracked by Wall St. Rank hold AVEO as of Q4 2022.

  • NEA Management Company reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • NEA Management Company sold 3,952,957 AVEO Pharmaceuticals, Inc. shares in Q4 2022, an estimated $32.5M.
  • NEA Management Company first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2016 and held it in 26 quarters.
  • NEA Management Company's AVEO Pharmaceuticals, Inc. position peaked at $61.9M in Q3 2018.
  • 110 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2022.

Based on NEA Management Company's 13F filing for Q4 2022, filed 10 Feb 2023.